{"title":"新城疫病毒灭活抗原定量ELISA检测系统的建立及Ph. Eur体外效价检测方法。","authors":"H L Oei","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The development of an alternative in vitro potency test required experimental studies, which were performed in-house and in collaboration with other laboratories (Official Medicines Control Laboratories, Manufacturers), coordinated by EDQM (European Directorate for the Quality of Medicines & HealthCare). This paper provides background information concerning the development of the quantitative ELISA for inactivated Newcastle disease virus (NDV) antigen, which was added in the European Pharmacopoeia monograph as an in vitro batch potency test.</p>","PeriodicalId":11190,"journal":{"name":"Developments in biologicals","volume":"134 ","pages":"51-3"},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The quantitative ELISA for inactivated Newcastle disease virus antigen: development of the test system and the way to a Ph. Eur in vitro potency test.\",\"authors\":\"H L Oei\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The development of an alternative in vitro potency test required experimental studies, which were performed in-house and in collaboration with other laboratories (Official Medicines Control Laboratories, Manufacturers), coordinated by EDQM (European Directorate for the Quality of Medicines & HealthCare). This paper provides background information concerning the development of the quantitative ELISA for inactivated Newcastle disease virus (NDV) antigen, which was added in the European Pharmacopoeia monograph as an in vitro batch potency test.</p>\",\"PeriodicalId\":11190,\"journal\":{\"name\":\"Developments in biologicals\",\"volume\":\"134 \",\"pages\":\"51-3\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Developments in biologicals\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Developments in biologicals","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The quantitative ELISA for inactivated Newcastle disease virus antigen: development of the test system and the way to a Ph. Eur in vitro potency test.
The development of an alternative in vitro potency test required experimental studies, which were performed in-house and in collaboration with other laboratories (Official Medicines Control Laboratories, Manufacturers), coordinated by EDQM (European Directorate for the Quality of Medicines & HealthCare). This paper provides background information concerning the development of the quantitative ELISA for inactivated Newcastle disease virus (NDV) antigen, which was added in the European Pharmacopoeia monograph as an in vitro batch potency test.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
